- Home
- NVCR vs AZTA Comparison
NVCR vs AZTA Comparison
Compare NVCR & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- AZTA
- Stock Information
- Founded
- NVCR 2000
- AZTA 1978
- Country
- NVCR Switzerland
- AZTA United States
- Employees
- NVCR N/A
- AZTA N/A
- Industry
- NVCR Medical/Dental Instruments
- AZTA Industrial Machinery/Components
- Sector
- NVCR Health Care
- AZTA Technology
- Exchange
- NVCR Nasdaq
- AZTA Nasdaq
- Market Cap
- NVCR 1.4B
- AZTA 1.4B
- IPO Year
- NVCR 2015
- AZTA 1995
- Fundamental
- Price
- NVCR $12.43
- AZTA $31.55
- Analyst Decision
- NVCR Buy
- AZTA Buy
- Analyst Count
- NVCR 7
- AZTA 4
- Target Price
- NVCR $28.79
- AZTA $42.00
- AVG Volume (30 Days)
- NVCR 1.9M
- AZTA 713.9K
- Earning Date
- NVCR 07-24-2025
- AZTA 08-05-2025
- Dividend Yield
- NVCR N/A
- AZTA N/A
- EPS Growth
- NVCR N/A
- AZTA N/A
- EPS
- NVCR N/A
- AZTA N/A
- Revenue
- NVCR $630,160,000.00
- AZTA $668,821,000.00
- Revenue This Year
- NVCR $6.68
- AZTA N/A
- Revenue Next Year
- NVCR $7.01
- AZTA $4.74
- P/E Ratio
- NVCR N/A
- AZTA N/A
- Revenue Growth
- NVCR 14.58
- AZTA 12.46
- 52 Week Low
- NVCR $10.87
- AZTA $23.91
- 52 Week High
- NVCR $34.13
- AZTA $55.64
- Technical
- Relative Strength Index (RSI)
- NVCR 46.30
- AZTA 53.22
- Support Level
- NVCR $11.55
- AZTA $29.14
- Resistance Level
- NVCR $12.26
- AZTA $31.16
- Average True Range (ATR)
- NVCR 0.46
- AZTA 1.53
- MACD
- NVCR 0.30
- AZTA 0.07
- Stochastic Oscillator
- NVCR 97.50
- AZTA 87.76
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About AZTA Azenta Inc.
Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.